Cargando…
Low-Dose Clozapine-Induced Agranulocytosis in Patients with Movement Disorders—Retrospective Study from India
Autores principales: | Choudhury, Supriyo, Banerjee, Sattwika, Chatterjee, Koustav, Basu, Purba, Baker, Mark R., Kumar, Hrishikesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680874/ https://www.ncbi.nlm.nih.gov/pubmed/35002172 http://dx.doi.org/10.4103/aian.AIAN_522_20 |
Ejemplares similares
-
Effect of Mask on Doctor–Patient Relationship during COVID-19: Indian Perspective
por: Banerjee, Sattwika, et al.
Publicado: (2022) -
AGRANULOCYTOSIS DURING CLOZAPINE THERAPY
por: Jagadheesan, K., et al.
Publicado: (2000) -
Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020) -
Levosulpiride-induced Movement Disorders
por: Choudhury, Supriyo, et al.
Publicado: (2017) -
Semantic Fluency Predicts Gait Velocity in PSP
por: Chatterjee, Koustav, et al.
Publicado: (2021)